Prognosis
US health lags other countries.
View in browser
Bloomberg

Prognosis is exclusively for Bloomberg.com subscribers. As a loyal reader, you’re receiving a complimentary trial. If you’d like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $149 for your first year (usually $299).

Hi, it’s Ike in Boston. I’ve got some bad news — health care keeps getting more expensive. More on that, but first ...

Today’s must-reads

  • A Senate confirmation hearing for surgeon general nominee Casey Means is being planned for next week.
  • UnitedHealth is testing the use of AI for medical claims processing.
  • An ex-Defense Department official has been tapped to run a federal health research funding organization.

Costs keep climbing

People in the US spend more money on health care than just about any other industrialized country, despite having some of the worst health outcomes. And prices are continuing to go up, according to an analysis released Wednesday.

Most people younger than 65 in the US get health insurance through their employer, and the average yearly premium for a family jumped 6% this year to nearly $27,000, according to an annual survey conducted by KFF, the health policy nonprofit. Employers pay most of that, with employees chipping in an average of $6,850.

“This is an expensive system that continues to get more expensive,” said Matthew Rae, an associate director at KFF who runs the survey. He noted that these numbers are just the amount of money people are paying for coverage — they don’t include co-pays or other out-of-pocket costs.

Health care costs are increasing and employers have relatively few tools to keep costs down, Rae said. Data collected in the survey show that most employers aren’t even using the scarce tools they do have, like restricting how much they will pay for certain procedures or limiting which health care providers are covered.

Among the factors that employers say are contributing to increasing health care costs are prescription drug prices, the prevalence of chronic diseases and the soaring use of GLP-1 drugs like Wegovy.

Nearly 60% of employers with at least 5,000 workers that cover GLP-1 drugs for weight loss say the cost has exceeded their expectations, according to the KFF survey. That could drive some companies to eliminate the coverage or add restrictions.

The skyrocketing levels of spending are not accompanied by excellent health. Life expectancy at birth in the US is well below several comparable countries. Rates of maternal mortality and obesity are higher as well.

High premiums are also keeping wages down. A study published last year showed that if employers allocated the same percentage of total compensation for health insurance as they did in 1988 for the next 30 years, the typical family would have taken home about $125,000 more over that period.

Data from the KFF survey also showed that premiums for family coverage have been rising more quickly than wages since 2015, except for the pandemic years of 2021 and 2022.

Rae said that costs may increase even more next year. “There are lots of indications that 2026 is going to be a bigger year for spending,” he said.

Indeed, JPMorgan Chase Chief Executive Officer Jamie Dimon said he thinks the bank will spend 10% more on employee health costs in 2026. And the consulting firm PwC expects costs for group health insurance, which includes employer-sponsored coverage, will increase by 8.5%, the same rate of increase seen this and last year. — Ike Swetlitz

What we’re reading

The Big Cities Health Coalition is the latest group to support vaccinations, according to CNN.

Congo has discharged its last Ebola patient, lifting hopes that the outbreak is over. Stat has the details.

Most adults have never heard of cardiovascular-kidney-metabolic syndrome though 90% of them are at risk, says a CBS News report.

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? There's more where that came from. Browse all our weekly and daily emails to get even more insights from your Bloomberg.com subscription.

Want to sponsor this newsletter? Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices